Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 360

Similar articles for PubMed (Select 18503697)

1.

Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.

Rech J, Hueber AJ, Kallert S, Leipe J, Kalden JR, Beck M, Schett G, Schulze-Koops H.

Ther Apher Dial. 2008 Jun;12(3):205-8. doi: 10.1111/j.1744-9987.2008.00573.x.

PMID:
18503697
2.

[Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].

Motoyama R, Yamakawa K, Suzuki S, Kusunoki S, Tanaka M.

Rinsho Shinkeigaku. 2011 Oct;51(10):761-4. Japanese.

PMID:
22019868
3.

Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.

Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B.

Ann Neurol. 2009 Mar;65(3):286-93. doi: 10.1002/ana.21577.

PMID:
19334068
4.

Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy.

Zara G, Zambello R, Ermani M.

Clin Neurophysiol. 2011 Dec;122(12):2518-22. doi: 10.1016/j.clinph.2011.05.015. Epub 2011 Jun 15.

PMID:
21680240
5.

[Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].

Drouet A, Caudie C, Vallat JM, Ruel JH, Felten D, Guilloton L, Giraud P.

Rev Neurol (Paris). 2006 Jun;162(6-7):760-6. French.

PMID:
16840988
6.

High-dose rituximab and anti-MAG-associated polyneuropathy.

Renaud S, Fuhr P, Gregor M, Schweikert K, Lorenz D, Daniels C, Deuschl G, Gratwohl A, Steck AJ.

Neurology. 2006 Mar 14;66(5):742-4.

PMID:
16534115
7.

Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A.

Clin Neurophysiol. 2002 Mar;113(3):346-53.

PMID:
11897535
8.

Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies.

Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, Gratwohl A, Steck AJ.

Muscle Nerve. 2003 May;27(5):611-5.

PMID:
12707982
9.

[A case of chronic demyelinating polyneuropathy with benign IgM anti-myelin-associated glycoprotein paraproteinenia--transient improvement with weekly plasmapheresis].

Muramoto T, Yamashita Y, Ohnishi A, Saito T, Kajiyama K, Shirokuchi A.

Rinsho Shinkeigaku. 1991 Jan;31(1):38-43. Review. Japanese.

PMID:
1710553
10.

Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.

Maisonobe T, Chassande B, Vérin M, Jouni M, Léger JM, Bouche P.

J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):36-42.

11.

Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M.

Benedetti L, Briani C, Grandis M, Vigo T, Gobbi M, Ghiglione E, Carpo M, Cocito D, Caporale CM, Sormani MP, Mancardi GL, Nobile-Orazio E, Schenone A.

J Peripher Nerv Syst. 2007 Jun;12(2):102-7.

PMID:
17565535
12.

Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sjögren's syndrome after Rituximab therapy.

Botez SA, Herrmann DN.

J Clin Neuromuscul Dis. 2010 Mar;11(3):127-31. doi: 10.1097/CND.0b013e3181c50513.

PMID:
20215986
13.

[Anti-MAG paraproteinemic demyelinating polyneuropathy: a clinical, biological, electrophysiological and anatomopathological descriptive study of a 13-patients' cohort].

Launay M, Delmont E, Benaim C, Sacconi S, Butori C, Desnuelle C.

Rev Neurol (Paris). 2009 Dec;165(12):1071-9. doi: 10.1016/j.neurol.2009.04.008. Epub . French.

PMID:
19487003
14.

Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titre in demyelinating paraproteinaemic polyneuropathy.

Gabriel JM, Erne B, Miescher GC, Miller SL, Vital A, Vital C, Steck AJ.

Brain. 1996 Jun;119 ( Pt 3):775-87.

15.

Rituximab therapy in monoclonal IgM-related neuropathies.

Kilidireas C, Anagnostopoulos A, Karandreas N, Mouselimi L, Dimopoulos MA.

Leuk Lymphoma. 2006 May;47(5):859-64.

PMID:
16753870
16.

Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.

Trojaborg W, Hays AP, van den Berg L, Younger DS, Latov N.

Muscle Nerve. 1995 Jul;18(7):730-5.

PMID:
7540258
17.

Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.

Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.

Neurology. 2009 Sep 1;73(9):688-95. doi: 10.1212/WNL.0b013e3181b59a80.

PMID:
19720975
18.

Delayed appearance of anti-myelin-associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy.

Valldeoriola F, Graus F, Steck AJ, Muñoz E, de la Fuente M, Gallart T, Ribalta T, Bombí JA, Tolosa E.

Ann Neurol. 1993 Sep;34(3):394-6.

PMID:
7689821
19.

[Polyneuropathies and gammapathies: a form with antiglycoprotein MAG antibodies].

Steck AJ, Meier C, Vandevelde M, Regli F.

Rev Neurol (Paris). 1984;140(1):28-36. French.

PMID:
6198705
20.

Antibody-associated polyneuropathy syndromes: principles and treatment.

Kornberg AJ, Pestronk A.

Semin Neurol. 2003 Jun;23(2):181-90. Review.

PMID:
12894383
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk